Denny Van Liew Email & Phone Number

New York, Ny, Us

Washington, Dc, Us

The Personalized Medicine Coalition (www.personalizedmedicinecoalition.org) promotes the advancement of personalized medicine by addressing regulatory, reimbursement, privacy, ethical, and educational issues critical to the field. Based on the diversity of its 250 members, PMC has become the preeminent voice shaping policy about and increasing investment in personalized medicine.

Yardley, Pa, Us

Red Nucleus is a leader in the life sciences industry, known for its extensive solutions in learning and development, scientific advisory, market access, and medical communications. We offer strategic insights and operational efficiencies that span the entire product lifecycle. We are recognized as a Great Place To Work® in multiple countries fostering an innovative and supportive workplace culture. As a trusted partner, we provide impactful solutions to help organizations navigate the complexities of the life sciences sector.

Princeton, New Jersey, Us

Responsible for working with drug developers and medical device companies to provide value-added pharmacovigilance, regulatory and medical information solutions for existing and new clients. Bioclinica provides science-driven services and technology-enabled solutions and offers a portfolio of products & services including end-to-end safety solutions supporting clinical safety and post-marketing pharmacovigilance activities.

Princeton, New Jersey, Us

Farnborough, England, Gb

Kinapse, a Syneos Health™ company, is a leading advisory and operational solutions provider to the global life sciences industry. The company delivers its services across the full clinical and commercialization continuum and across global markets, collaborating with its biopharmaceutical customers to improve patients’ lives. Through a unique Advise – Build – Operate model, Kinapse delivers quantifiable business benefits and operational success. Headquartered in the U.K., Kinapse has more than 600 staff located in Europe, India and the U.S. Learn more at kinapse.com.

Farnborough, England, Gb

Denny is a Managing Director and Head of Kinapse, Inc. (US) Cambridge, MA office. The Greater Boston area is one of the fastest growing offices in Kinapse Americas, with an office culture that matches the energy and internationality of the biopharma, medical device and healthcare community located in this dynamic metropolitan area.

Farnborough, England, Gb

Senior adviser working with life science companies in both biopharma and medical device sectors on variety of assignments including new company start-ups including regulatory approval pathways, strategic sourcing, acquistion integration and divestiture, and complex program management. Special expertise in safety and regulatory business strategy and operations improvement.

New York, New York, Us

Led key Pfizer transformation projects saving $858M, including regulatory and safety function integration and divisional change initiatives. Developed strategies for Pfizer’s R&D open innovation in Europe and a new business model for Worldwide Safety Sciences, yielding a 20% productivity increase and $23.3M in savings. Directed the integration of PowderMed and Coley Pharmaceuticals into Pfizer, enhancing the Vaccines Research Center of Excellence and supporting ViiV startup. Contributed to Pfizer’s eHealth and Personalized Medicine projects. Secured strategic partnership for safety operation services and led the divestiture of surplus R&D assets globally, realizing $330M in savings. Mentored colleagues in career development and led a Global Regulatory Data Quality program, ensuring accurate product registration for global users

New York, New York, Us

Senior leadership innovator in the planning, development and improvement of the overall WSR business model, and leading initiatives to improve work processes and strategic partner/alliance management activities beginning with Wyeth acquisition in 2009.Key role highlights:Leading Pfizer Consumer Health Regulatory Benchmarking initiative to deliver first comprehensive industry survey (2014); Lead author, WSR 2014-16 Strategic Business Plan (2013-14), Led Global Regulatory System (GRS) Sustainable Quality Initiative (2012-13), led new EU PV (Safety) Legislation Compliance Initiative (2012-13), led Project Management and Sourcing team (2012), and led PMO for Safety Operations optionality review resulting in new sourcing model (2011-12).

New York, New York, Us

Global secondment assignment: Provided strategy advice and goals setting support to Sandwich Labs Leadership Team. Enhanced external collaboration strategy for European R+D, led development of 2nd horizon Sandwich strategy and provided integration leadership to Coley Pharmaceuticals acquisition.

New York, New York, Us

Senior leader in the strategy group. Responsible for providing strategy advice and goals setting support to R&D leadership within this $5.6B division. Member of Groton-New London Leadership Team. Project portfolio includes PGRD continuous improvement effort and strategy development for Comparative Medicine, Pharmacogenomics, and Nanotechnology. Actively providing support to Pfizer senior leadership on healthcare information technology (HIT) external influence strategy. Responsible for managing use and acquisition of management consulting services to address key business issues facing the division.Responsible for SMG summer intern program. Previously served as senior strategy advisor to Vice President, Informatics and Senior Vice President, Safety Sciences. Led first major functional support lines restructuring initiative (30% cost reduction) and developed IP Defensive Strategy framework.

Gb

Headhunted from London to join Washington, D.C. practice office. Provided operations strategy services to academic medical centers, a large managed care organization and worked with trade association on marketplace positioning issues. Transferred to public sector practice to support the Department of Veterans Affair by: managing Federal account contract vehicle (20 – 25 projects/$10M in fees per annum), co-managing a large clinical care program evaluation project (11,000 hours) and directly participated in several smaller process improvement projects.

New York, Ny, Us

Co-founded UK healthcare risk management (RM) company for US parent company (now The Travelers) dedicated to enhancing the safety of healthcare delivery. Within 5 years, firm gained number one market share in UK & Ireland. Responsible for sale and implementation of RM information systems.

London, Gb

Ran $31M resource management program (managed 12 direct/18 indirect staff). Achieved cost improvements of >$100M via disease management models, clinical directorate development and IT systems investments at a $2.5B public sector health care service provider

Minneapolis, Mn, Us

Managed $2.9M budget and 120 employees for this integrated delivery network. Responsible for the clinical quality management program, social work services, senior services, the accounts receivable management program at the local level, internal consulting & TQM program, admitting and patient representatives

Worldwide, Oo

Provided consulting services to more than 30 health care organizations in the areas of operations/service/quality improvement and strategic planning identifying nearly $20M in cost avoidance and cost reduction. Developed and sold a decision support tool for productivity analysis aimed at US healthcare providers.

Certificate, Pharmaceutical Drug Development

Msie, Concentration On Health Systems Design

Bachelor Of Science (Bs), Industrial Engineering

Green Belt And Lean Certification, Lean Six Sigma

Education record